We are live on ! Find out more
PD

Point72 (DIFC) Portfolio holdings

AUM $1.53B
1-Year Est. Return 15.83%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+15.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.53B
AUM Growth
-$1.12B
Cap. Flow
-$1.18B
Cap. Flow %
-77.26%
Top 10 Hldgs %
24.76%
Holding
1,997
New
503
Increased
228
Reduced
373
Closed
880

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$44.7M
2
MSFT icon
Microsoft
MSFT
+$41.9M
3
BSX icon
Boston Scientific
BSX
+$27.2M
4
V icon
Visa
V
+$26.6M
5
TSM icon
TSMC
TSM
+$25.3M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$30.4M
2
ADI icon
Analog Devices
ADI
+$24.4M
3
TMO icon
Thermo Fisher Scientific
TMO
+$24.4M
4
GE icon
GE Aerospace
GE
+$22.9M
5
LRCX icon
Lam Research
LRCX
+$21.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.12%
2 Technology 23.11%
3 Financials 13.26%
4 Communication Services 8.27%
5 Consumer Discretionary 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSQ icon
1076
Townsquare Media
TSQ
$104M
$625 ﹤0.01%
+93
New +$673
DNLI icon
1077
Denali Therapeutics
DNLI
$3.82B
$622 ﹤0.01%
+43
New +$618
SPOK icon
1078
Spok Holdings
SPOK
$227M
$601 ﹤0.01%
+35
New +$623
ACHV icon
1079
Achieve Life Sciences
ACHV
$634M
$595 ﹤0.01%
+189
New +$519
STHO icon
1080
Star Holdings Shares of Beneficial Interest
STHO
$114M
$593 ﹤0.01%
72
-828
-92% -$6.72K
SGMO
1081
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$587 ﹤0.01%
871
-323
-27% -$174
CDLX icon
1082
Cardlytics
CDLX
$22.3M
$558 ﹤0.01%
23
UA icon
1083
Under Armour Class C
UA
$2.97B
$545 ﹤0.01%
+113
New +$632
BDTX icon
1084
Black Diamond Therapeutics
BDTX
$101M
$544 ﹤0.01%
143
-7,081
-98% -$20.7K
IPSC icon
1085
Century Therapeutics
IPSC
$370M
$530 ﹤0.01%
1,064
-685
-39% -$369
CCCC icon
1086
C4 Therapeutics
CCCC
$393M
$519 ﹤0.01%
234
-3,719
-94% -$8.93K
GEOS icon
1087
Geospace Technologies
GEOS
$88.4M
$507 ﹤0.01%
+27
New +$437
ONL
1088
Orion Office REIT
ONL
$148M
$491 ﹤0.01%
182
-14,053
-99% -$37.6K
PRPL icon
1089
Purple Innovation
PRPL
$35.7M
$464 ﹤0.01%
20
FLL icon
1090
Full House Resorts
FLL
$83.8M
$462 ﹤0.01%
144
-2,423
-94% -$9.52K
CXM icon
1091
Sprinklr
CXM
$1.48B
$430 ﹤0.01%
+56
New +$472
YSG
1092
Yatsen Holding
YSG
$322M
$425 ﹤0.01%
47
-5
-10% -$48
OCGN icon
1093
Ocugen
OCGN
$420M
$422 ﹤0.01%
259
-16,609
-98% -$18.4K
RAPT
1094
DELISTED
RAPT Therapeutics
RAPT
$405 ﹤0.01%
+16
New +$209
AMTX icon
1095
Aemetis
AMTX
$104M
$383 ﹤0.01%
170
-646
-79% -$1.72K
GDRX icon
1096
GoodRx Holdings
GDRX
$1.06B
$382 ﹤0.01%
90
-2,440
-96% -$10.7K
DCGO icon
1097
DocGo
DCGO
$62.4M
$379 ﹤0.01%
+279
New +$422
LTRX icon
1098
Lantronix
LTRX
$238M
$352 ﹤0.01%
+77
New +$285
CTM icon
1099
Castellum
CTM
$67M
$337 ﹤0.01%
+309
New +$359
MGNX icon
1100
MacroGenics
MGNX
$245M
$319 ﹤0.01%
190

Similar funds

Point72 (DIFC)'s Q3 2025 Portfolio in Review

As of Q3 2025, Point72 (DIFC) held 1,997 positions worth $1.53B, down 42% from $2.64B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Point72 (DIFC) withdrew a net $1.18B in Q3 2025, closing 880 positions and reducing 373 holdings. Its most notable exit was NVIDIA, an estimated $30.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

Against the trend, Point72 (DIFC) opened a new position in Visa worth $26.2M.

  • Point72 (DIFC)'s largest Q3 2025 buy was Visa: 76,800 shares worth $26.2M.
  • Point72 (DIFC) added most to Meta Platforms (Facebook) in Q3 2025, an estimated $44.7M increase.
  • Point72 (DIFC)'s biggest Q3 2025 reduction was Analog Devices, cutting an estimated $24.4M.
  • Point72 (DIFC) fully exited NVIDIA in Q3 2025, selling an estimated $30.4M.
  • Point72 (DIFC)'s ten largest holdings make up 25% of its $1.53B portfolio in Q3 2025.
  • Point72 (DIFC) opened 503 new positions and closed 880 in Q3 2025.
  • Point72 (DIFC)'s portfolio value fell 42% quarter-over-quarter to $1.53B.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.